Amy Camuso
About
In The Last Decade
Amy Camuso
12 papers receiving 393 citations
Peers
Comparison fields: 5 of 51
- Oncology 163
- Hematology 162
- Genetics 114
- Molecular Biology 113
- Rheumatology 84
Countries citing papers authored by Amy Camuso
This map shows the geographic impact of Amy Camuso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Camuso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Camuso more than expected).
Fields of papers citing papers by Amy Camuso
This network shows the impact of papers produced by Amy Camuso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Camuso. The network helps show where Amy Camuso may publish in the future.
Co-authorship network of co-authors of Amy Camuso
This figure shows the co-authorship network connecting the top 25 collaborators of Amy Camuso. A scholar is included among the top collaborators of Amy Camuso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Camuso. Amy Camuso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 43 | |
| 2 | 28 | |
| 3 | 113 | |
| 4 | 60 | |
| 5 | BMS-354825 potently inhibits multiple selected oncogenic tyrosine kinases and possesses broad-spectrum antitumor activities in vitro and in vivo | 38 |
| 6 | 66 | |
| 7 | 22 | |
| 8 | 14 | |
| 9 | 5 | |
| 10 | Pharmacodynamic analysis of target inhibition and tumor endothelial cell death in biopsies obtained from patients treated with the VEGF receptor antagonists SU5416 or SU6668 | 3 |
| 11 | 1 | |
| 12 | 9 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.